- Home
- Past Conferences
- #2 Cardiovascular Disease Prevention
#2 Cardiovascular Disease Prevention
New Guidelines and Global Strategies for Reducing Cardiovascular Risk
21 Sep - 24 Sep 2014
El Jadida, Morocco
-
Nathan Wong
University of California, Irvine
-
Ian Graham
Trinity College
Early Bird - Expired • Talk Submission - Expired • Poster Submission - Expired • Registration & Payment Deadline - Expired
Report
This major conference on Cardiovascular Disease Prevention took place in El Jadida, Morocco, from 21 to 24 September 2014. Its significance was marked by the endorsement by major bodies involved in CVD prevention, notably the European Society of Cardiology, the World Heart Federation, Tous Avec La Coeur (the Moroccan CVD prevention foundation), European Association for Cardiovascular Prevention and Rehabilitation, American Society for Preventive Cardiology, the American College of Cardiology and the California Chapter of the American College of Cardiology.
The meeting was Chaired by Dr Ian Graham (Trinity College, Dublin and the European Society of Cardiology) and Dr. Nathan D. Wong (University of California, Irvine, USA).
Faculty included Dr. Shanthi Mendis (WHO Senior Advisor on non-communicable diseases), Dr. Laurence Sperling (Emory University and American Society for Preventive Cardiology), Kathryn Taubert (American Heart Association), Maciej Banach (Medical University of Lotz, Poland and Polish Lipid Association), Kornelia Kotseva (Imperial College London) and Yaakov Henkin (Soroka Medical Centre, Israel).
The local Moroccan Faculty was equally distinguished and included Dr. Mohamed Alami, Dr. Noureddine Chaouki (Former Director of the Epidemiolgy Department at the Moroccan Ministry of Health), Prof. Abir Saadia (President of the Moroccan Society of Cardiology) and Mrs. Amal Mouzouni (Product Manager, Tecnimede Group).
The mix of skills present, together with a high degree of interactivity, resulted in a meeting of remarkably high quality. The principles of CVD risk estimation and CVD prevention and risk factor control at individual, community and international levels were clearly defined. Current American and European CVD Prevention Guidelines were presented and debated in a robust yet constructive manner. The Moroccan input included a review of their current situation regarding CVD risk factor prevalence and prevention efforts that included active and productive discussion about the challenges and solutions with regards to CVD in Morocco, from the practical to the political, and international implications arising. Active suggestions were discussed with key discussions for future collaborations regarding national CVD survey planning and implementation and development of audit/registries.
The participation of the WHO, AHA, ESC and European Association of Cardiovascular Prevention and Rehabilitation (EACPR) at the highest level led to a workshop atmosphere with the beginning of a strategy to develop mutually supportive future activities in line with the international trend towards a more integrated global approach to CVD prevention.
The meeting was seamlessly organized by Fusion Conferences, Ltd.
Tecnimede Ltd generously and enthusiastically supported the meeting in many ways, and the generous support of Sanofi is also gratefully acknowledged.
Synopsis
Scientific programme endorsed by the European Association for Cardiovascular Prevention and Rehabilitation (EACPR), a registered branch of the European Society of Cardiology (ESC).
Also endorsed by the Moroccan CVD Prevention Association (TAC), the Moroccan Society of Cardiology (SMC), the American Society for Preventive Cardiology and the World Heart Federation.
Key Sessions
- Risk Assessment and Prevention
- Global Concepts in CVD Prevention and Newer Guidelines
- Guidelines for Europe and America: Understanding the Differences (Organised by EACPR)
- CVD Prevention in Morocco
- Are Current Guidelines Relevant or Helpful?
- Moving Forward to Promote Prevention
Educational Objectives
After this meeting, it is hoped that delegates will be able to:
- Understand the key features of the current European and American Guidelines on CVD prevention, their relevance to Europe and America, and adaptability for developing countries.
- Understand the cycle of evidence-based guidelines, implementation, and evaluation/monitoring.
- Understand the rationale for and limitations of risk assessment, screening for CVD and their role in prevention.
- Examine the key evidence behind specific lifestyle recommendations for CVD prevention.
- Examine new and emerging therapies and their efficacy and potential role in CVD prevention.
Target Audience
Confirmed Speakers Include
Head for Non-communicable Diseases, World Heart Federation
American Heart Association
Maciej Banach
Polish Lipid Association
Kornelia Kotseva
Imperial College London
Larry Sperling
Emory Healthcare
Yaakov Henkin
Soroka University Medical Center
Mohamed Alami
CVD Prevention Association Tous avec le coeur (TAC)
Confirmed Speakers
Chairs
Nathan Wong
Professor and Director, Heart Disease Prevention Program, University of California, Irvine
Ian Graham
Professor of Cardiovascular Medicine, Trinity College
Invited Speakers
Shanthi Mendis
Senior Adviser, NCDs, World Health Organization
Maciej Banach
Professor, Medical University of Lodz
Kathryn Taubert
Vice President, American Heart Association
Kornelia Kotseva
Professor of Cardiovasculalar Epidemiology and Prevention , Cardiovascular Medicine, National Heart & Lung Institute,Imperial College London
Yaakov Henkin
Cardiologist, Soroka University Medical Center
Laurence Sperling
President / Professor/ Director of The Center for Heart Disease Prevention, American Society for Preventive Cardiology/ Emory Univ. School of Medicine
MOHAMED ALAMI
Professor of Cardiology, Cabinet de Cardiologie Ghandi
Programme
Sunday 21st September 2014 |
||
|
15:00 – 17:15 |
Registration & Reception |
|
|
17:30 – 17:50 |
Opening Comments |
|
|
Risk Assessment & Prevention |
||
|
17:50 – 18:10 |
Ian Graham |
NEW PERSPECTIVES ON CVD RISK ESTIMATION |
|
18:10 – 18:30 |
Nathan Wong |
RISK SCORING AND CVD RISK ASSESSMENT: ACC/AHA GUIDELINES |
|
18:30 – 18:50 |
Noureddine Chaouki |
OVERWEIGH AND OBESITY PROFILE IN MOROCCO AND OTHER CVD RISK FACTORS |
|
18:50 – 19:10 |
Laurence Sperling |
FOCUS ON CV HEALTH (NOT DISEASE) |
|
19:10 – 19:30 |
Panel Discussion |
|
|
19:30 – 20:00 |
Refreshments |
|
|
20:00 |
Group Dinner & Free Time |
|
Monday 22nd September 2014 |
||
|
Global Concepts in CVD Prevention and Newer Guidelines |
||
|
08:30 – 08:50 |
Shanthi Mendis |
THE GLOBAL CVD PREVENTION AGENDA |
|
08:50 – 09:10 |
Ian Graham |
THE GLOBAL CVD PREVENTION AGENDA: CAN EUROPE HELP? |
|
09:10 – 09:30 |
Kathryn Taubert |
GLOBAL PREVENTION OF CVD IN WOMEN |
|
09:30 – 09:50 |
Kathryn Taubert |
WHAT ARE THE ACHIEVABLE GOALS IN HEART HEALTH FOR CHILDREN? |
|
09:50 – 10:10 |
Panel Discussion |
|
|
10:10 – 10:40 |
Refreshments |
|
|
10:40 – 11:00 |
Nathan Wong |
DIABETES AND CVD: GUIDELINES FOR PREVENTION |
|
11:00 – 11:20 |
Maciej Banach |
PREHYPERTENSION AND IMPLICATIONS FOR GLOBAL CVD PREVENTION |
|
11:20 – 11:40 |
Handrean Soran |
THE IMPORTANCE OF CONSIDERING LOW-DENSITY LIPOPROTEIN CHOLESTEROL RESPONSE, NUMBER NEEDED TO TREAT AS WELL AS CARDIOVASCULAR RISK IN DECIDING WHO CAN BENEFIT FROM STATIN THERAPY. |
|
11:40 – 12:00 |
Handrean Soran |
A COMPARISON OF LOW AND HIGH DOSE ATORVASTATIN ON ACHIEVING APOLIPOPROTEIN B100, LDL-C AND NON-HDL-C THERAPEUTIC TARGETS, HDL FUNCTIONALITY, MODIFIED LDL AND INFLAMMATORY CYTOKINES OVER ONE YEAR IN TYPE 2 DIABETES: THE PROTECTION AGAINST NEPHROPATHY IN DIABETES WITH ATORVASTATIN (PANDA) TRIAL |
|
12:00 – 12:20 |
Panel Discussion |
|
|
12:20 – 17:00 |
Group Lunch & Free Time |
|
|
14:00 – 17:00 |
Group Tour to El Jadida (optional) |
|
|
Guidelines for Europe and America: Understanding the Differences (Organised by EACPR) |
||
|
17:00 – 17:30 |
Ian Graham |
EUROPEAN GUIDELINES ON CVD PREVENTION |
|
17:30 – 17:50 |
Nathan Wong |
OVERVIEW OF ACC/AHA GUIDELINES FOR CVD PREVENTION |
|
17:50 – 18:10 |
Maciej Banach |
EUROPEAN AND AMERICAN GUIDELINES FOR HYPERTENSION MANAGEMENT: ARE THEY COMPATIBLE? |
|
18:10 – 18:30 |
Panel Discussion |
|
|
18:30 – 19:30 |
Moderated Poster Session & Cocktail Reception (3min per presenter) |
|
|
19:30 |
Group Dinner & Free Time |
|
Tuesday 23rd September 2014 |
||
|
CVD Prevention in Morocco |
||
|
08:30 – 08:50 |
Mohamed Alami |
CVD SCREEN AND PREVENTION EFFORTS IN MOROCCO |
|
08:50 – 09:10 |
Derouiche Abdelfettah |
NON-COMMUNICABLE DISEASES IN CASABLANCA-MOROCCO |
|
09:10 – 09:30 |
Habbal Rachida et al |
EPIDEMIOLOGICAL PROFILE OF THE HYPERTENSION AND THE ACCESION TO THE RECOMMENDATIONS OF THE MOROCCAN PATIENT |
|
09:30 – 10:00 |
Refreshments |
|
|
10:00 – 10:20 |
Habbal Rachida et al |
SERUM LIPID PROFILE IN HYPERTENSIVE PATIENTS IN THE UNIVERSITY HOSPITAL OF CASABLANCA |
|
10:20 – 10:40 |
Panel Discussion |
|
|
10:40 – 17:00 |
Group Lunch & Free Time |
|
|
Are Current Guidelines Relevant or Helpful? |
||
|
17:00 – 17:20 |
Ian Graham |
EUROPE |
|
17:20 – 17:40 |
Laurence Sperling |
USA |
|
17:40 – 18:00 |
Mohamed Alami |
GLOBAL RISK SCORING IN MOROCCO: WHAT IS NEEDED FOR MOROCCO? |
|
18:00 – 18:20 |
Panel Discussion |
|
|
18:20 – 19:00 |
Refreshments |
|
|
20:00 |
*Gala Night & Group Photo* |
|
Wednesday 24th September 2014 |
||
|
Moving Forward to Promote Prevention || The Future of Prevention |
||
|
08:30 – 08:50 |
Shanthi Mendis |
THE WHO PROGRAMME FOR THE CONTROL OF CVD AND OTHER CHRONIC DISEASES; ADDED VALUE FROM AN INTEGRATED APPROACH |
|
08:50 – 09:10 |
Ian Graham |
THE ROLE OF AUDIT IN CVD PREVENTION |
|
09:10 – 09:30 |
Kornelia Kotseva |
EUROASPIRE IV: FINDINGS AND IMPLICATIONS IN SECONDARY PREVENTION |
|
09:30 – 09:50 |
Panel Discussion |
|
|
09:50 – 10:30 |
Refreshments |
|
|
10:30 – 10:50 |
Yaakov Henkin |
IMPLEMENTING PREVENTION - LESSONS FROM THE EUROPEAN PREVENTION IMPLEMENTATION COMMITEE AND THE COUNTRY OF THE MONTH PROJECT |
|
10:50 – 11:30 |
Final Panel Discussion |
|
|
11:30 – 11:45 |
Closing Remarks (Chairs & Fusion) |
|
Supported by
Venue & Location
Mazagan Beach Resort
Relax in the warm Moroccan sun at the Mazagan Beach Resort, a truly beautiful hotel situated along the coast with stunning panoramic views across the Atlantic Ocean. The resort combines traditional Moroccan culture with a modern twist creating an unforgettable conference experience for all.
The resort covers over 250 hectares offering an amazing array of activities and entertainment for delegates to choose from during their free time at the conference.
Throughout your stay delegates will enjoy a buffet feast for breakfast, lunch and dinner. During each meal delegates are entitled to selected beverages and 1 glass of house wine during dinner. The themed Moroccan Gala Night takes place on the third evening of the conference with a mouth-watering feast of local cuisine, an open bar and live performing band. We welcome all delegates and their accompanying persons to the Gala Night – a truly fun filled night not to be missed!
Hotel Facilities
- Beach
- Resort Swimming Pool
- Fitness Centre
- Wellness Spa
- Complimentary WI-FI in guestrooms and conference areas
General Information
Venue Rating
★ ★ ★ ★ ★
Currency
US Dollar (USD)
Address
Nearest Airport
Mohammed V International Airport (CMN)
Location
Morocco has over 2000miles of unspoilt sandy beaches, more than 300 days of sunshine per year and with its warm, friendly, hospitable people and delicious cuisine Morocco creates a perfect and unique location to hold a conference! Morocco is an ethnically diverse country with a rich culture and history. The region offers something for everyone, whether you like exploring the old winding medinas of its cities and towns, strolling along the stunning beaches, hiking the temperate peaks of the Rif mountain range or tasting some of the countries diversified cuisine.
Not far from the Mazagan Beach Resort is the Portuguese City of Mazagan, now known as El Jadida. It is one of the early settlements of the Portuguese explorers in West Africa on the route to India - it is an outstanding example of the interchange of influences between European and Moroccan cultures, well reflected in architecture, technology, and town planning. Popular sites include; The Municipal Theater of El Jadida, The Portuguese Cistern, The Canons and the Fortress and The Old Port. El Jadida is definitely a city worth visiting during your stay.
Gallery
View on FlickrConference History
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
If you are interested in this meeting but not yet ready to register, you can sign up for updates here and our team will keep you updated regarding deadline reminders and grant opportunities relating to this meeting only.
Diamond Sponsors
Platinum Sponsors
If you're interested in sponsoring this conference please contact us.
Conference Manager
Laura Trundle
Need some help? Chat to the Fusion team today
As a family run business, our dedication runs deep. We’re committed to each other and, even more so, to every attendee’s experience, delivering a level of care and passion that’s truly unmatched.
